Keywords: Amylin, Quarter ended March 2012 financial results, Carl Icahn, Drops law suit

Amylin operating loss leaps to over $30 million

Article | 27 April 2012

US biotech firm Amylin Pharmaceuticals (Nasdaq AMLN): reported financial results for the quarter ended March 31, 2012, with total revenues coming in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Amylin

Go to company listing